Doctor v Forest Laboratories (AUTH/2304/3/10): Exorex journal ad featuring woman in underwear – no breach

📅 2010 | 🖉 Dr Anzal Qurbain
📊

Key facts

CaseAUTH/2304/3/10
PartiesDoctor v Forest Laboratories UK Limited
ProductExorex Lotion (coal tar solution 5% v/w cutaneous emulsion)
MaterialJournal advertisement
IssueAlleged inappropriate/sexualised imagery (woman in underwear in a supermarket; man looking on)
Applicable Code year2008
Clauses considered9.1 and 9.2
DecisionNo breach
Complaint received16 March 2010
Case completed13 April 2010
AppealNo appeal

Download the full case report (PDF)


Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory

🤖

Got a question about this case?

Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.

Ask AskAnzal AI
🎬 Expert Video Walkthrough
🎬
Video walkthrough — coming for members
Subscribe now and get expert video analysis for every case as we publish them.
Subscribe — from £299/yr
📋

What happened

  • A doctor complained about a medical journal advertisement for Exorex Lotion (coal tar solution 5% v/w cutaneous emulsion) by Forest Laboratories UK Limited.
  • The ad showed a young woman walking through a supermarket in her underwear, with a man looking on open-mouthed.
  • The complainant felt a sexual element had been introduced and that this style was inappropriate for prescription medicines.
  • The PMCPA asked Forest to respond in relation to Clauses 9.1 and 9.2 (high standards; not likely to cause offence).
  • Forest argued the imagery was relevant to psoriasis (skin visibility), focused on confidence/self-esteem, and was consistent with dermatology advertising practice; the claim “Exorex. It has been known to improve confidence.” appeared next to the image.
⚖️

Outcome

  • No breach of the Code was ruled.
  • No breach of Clauses 9.1 and 9.2.
  • The Panel considered the image attention-grabbing but relevant to the therapeutic area and unlikely to offend the majority of the intended audience.
🔒

Unlock the full case analysis

Members get the complete breakdown — Clauses, Sanction, Signatory Lens, Audit checklist, and 3 Key Questions.

Best value
£249/year
Annual — save £99
or
£29/mo
Monthly
Join Now — Instant Access

⭐ Business Intelligence Access

See the full compliance picture for every pharma company

291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.

Request Access →
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training